Piedmont Lithium (ASX:PLL) and Atlantic Lithium (ASX:A11) hit back at Blue Orca
Nick Sundich, March 10, 2023
Piedmont Lithium (ASX:PLL) and Atlantic Lithium (ASX:A11) have responded to a report from short-seller Blue Orca Capital.
The latter company (Atlantic) has a lithium project in Ghana that it aspires to bring into production while the former company (PLL) is a substantial shareholder of Atlantic.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
PLL and A11 think they can built Ghana’s first lithium mine, Blue Orca disagrees
PLL and A11 are hoping its Ewoyaa project can become Ghana’s first lithium mine.
A PFS was unveiled in September, outlining a 2Mtpa (million tonnes per annum) operation over 12.5 years with an initial capital investment of US$125m. At a grade of 6% lithium, this would equate to 255,000 tpa.
Blue Orca released a report yesterday, alleging that A11 obtained these licenses by making secret payments and promises of payments to the family of a high-level politician. It also said the mining licenses A11 held would not be granted in the end.
The companies refute the allegations
Both companies have responded to the claims.
A11 stated that it held valid prospecting licenses in accordance with all legal requirements and outright refuted the allegations. The company also said it believes that it would be granted a mining license in due course and that it would see legal advice to address the claims.
PLL also released a statement in which it denied the allegations and stated it was seeking legal advice.
Additionally, PLL stated that even if A11 was not granted a mining license, it would readily have alternative sources of spodumene concentrate for its Tennessee facility.
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Kamala Harris stocks: If Joe Biden’s VP wins the White House in 2024, which stocks will win?
With the US Presidential election now certain to be a Kamala Harris v Donald Trump showdown, we’ve looked at so-called…
South32 (ASX:S32): Is it the dark horse amongst ASX 200 miners or have cyclones and commodity prices hit it too hard?
South32 (ASX:S32) began life as a spinoff from BHP back in 2015, capitalised at $9bn. In mid-2024, it is capped…
Here’s why drug reimbursement is so important for ASX healthcare stocks
Let’s take a look at the concept of drug reimbursement, something that is crucial for ASX healthcare stocks looking to…